IBRUTINIB, PIRTOBRUTINIB, PIRTOBRUTINIB
LOXO-BTK-20030
Phase 3 small_molecule active
Quick answer
IBRUTINIB, PIRTOBRUTINIB, PIRTOBRUTINIB for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma is a Phase 3 program (small_molecule) at Ology Bioservices Ireland LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ology Bioservices Ireland LTD
- Indication
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active